Form 4: Orthofix Medical Inc. CAO Sells Shares to Cover Tax Obligations

Orthofix Medical Inc.'s Chief Accounting Officer, Geoffrey C. Gillespie, sold shares of common stock to cover tax obligations related to the settlement of restricted stock units.

Summary

• Geoffrey C. Gillespie, the Chief Accounting Officer of Orthofix Medical Inc., sold a total of 476 shares of common stock on January 7th and 8th, 2025.
• These sales were made to satisfy tax withholding obligations related to the settlement of restricted stock units.
• The sales were executed under a pre-existing sell-to-cover requirement mandated by the company's Compensation and Talent Development Committee.
• The shares were sold in multiple transactions at weighted average prices of $17.1352 on January 7th and $16.9718 on January 8th.
• Following these transactions, Gillespie beneficially owns 40,565 shares of common stock, which includes 37,206 previously reported restricted stock units.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction for tax purposes, with no indication of positive or negative sentiment.

Industry Context

This is a routine transaction for executives who receive stock-based compensation. It is common for executives to sell shares to cover tax obligations when restricted stock units vest.

Comparison to Industry Standards

• Executive stock sales to cover tax obligations are a common practice across publicly traded companies.
• The sale of shares by Geoffrey C. Gillespie is consistent with standard procedures for executives receiving stock-based compensation.
• Similar transactions are regularly reported by executives at comparable medical device companies.

Stakeholder Impact

• The stock sales have a minimal impact on shareholders as they are routine transactions for tax purposes.
• The sales do not indicate any change in the company's performance or outlook.

Key Dates

Keywords

Orthofix Medical Inc., Geoffrey C. Gillespie, stock sale, restricted stock units, tax obligations, Form 4, insider trading